ArticleCell death & disease2014

Bortezomib sensitises TRAIL-resistant HPV-positive head and neck cancer cells to TRAIL through a caspase-dependent, E6-independent mechanism.

J Bullenkamp et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.